Aquesta web utilitza cookies per a obtenir dades estadístiques de la navegació dels seus usuaris. Si continues navegant considerem que acceptes el seu ús. | Més informació

Inici

Fundació per a la Investigació i la Docència Maria Angustias Giménez

Arxiu de publicacions en Revistes indexades: 227 articles.
1,134 punts de Factor d'Impacte (FI).

ANY TÍTOL AUTORS REVISTA FI
2012 Semantic Distance Abnormalities in Mild Cognitive Impairment: Their Nature and Relationship to Function Brady C. Kirchberg, Jessica R. Cohen, Margarita B. Adelsky, Justin J. Buthorn, Jesus J. Gomar, Marc Gordon, Jeremy Koppel, Erica Christen, Concepcion Conejero-Goldberg, Peter Davies and Terry E. Goldberg. American Journal of Psychiatry 12.295
2012 One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis. San L, Arranz B, Perez V, Safont G, Corripio I, Ramirez N, Dueñas R, Alvarez E. Psychiatry Research 2.467
2012 Why are psychiatric imaging methods clinically unreliable? Conclusions and practical guidelines for authors, editors and reviewers Borgwardt S, Radua J, Mechelli A, Fusar-Poli P Behavioral and Brain Functions 1.972
2012 The missing link between faces and names: Evidence from Alzheimer's disease patients Calabria M, Sabio A, Martin C, Hernández M, Juncadella M, Gascón-Bayarri J, Reñé R, Ortiz-Gil J, Ugas L, Costa A Brain and Cognition 2.477
2012 Meta-analysis of fMRI studies of timing in Attention Deficit Hyperactivity Disorder (ADHD) Hart H, Radua J, Mataix-Cols D, Rubia K Neuroscience and Biobehavioral Reviews 8.802
2012 Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication Radua J, Borgwardt S, Crescini A, Mataix-Cols D, Meyer-Lindenberg A, McGuire PK, Fusar-Poli P Neuroscience and Biobehavioral Reviews 8.802
2012 Interaction of catechol O-methyltransferase and serotonin transporter genes modulates effective connectivity in a facial emotion-processing circuitry Surguladze SA, Radua J, El-Hage W, Gohier B, Sato JR, Kronhaus DM, Proitsi P, Powell J and Phillips ML Translational Psychiatry 5.62
2012 Effect of the Interleukin-1beta Gene on Dorsolateral Prefrontal Cortex Function in Schizophrenia: A Genetic Neuroimaging Study Mar Fatjó-Vilas, Edith Pomarol-Clotet, Raymond Salvador, Gemma C Monté, Jesús J Gomar, Salvador Sarró, Jordi J Ortiz-Gil, Candibel Aguirre, Ramón Landin-Romero, Amalia Guerrero-Pedraza, Sergi Papiol, Josep Blanch, Peter J McKenna, Lourdes Fañanás Biological Psychiatry 10.255
2012 Meta-analytic methods for neuroimaging data explained Radua J, Mataix-Cols D Biology of mood & anxiety disorders  
2012 Intra- and inter-observer agreement among bronchial endosonographers for the description of intrathoracic lymph nodes Garcia-Olive I, Radua J, Serra P, Andreo F, Sanz-Santos J, Monso E, Rosell A, Cases-Viedma E, Fernandez-Villar JA, Nuñez-Delgado M, Garcia-Lujan R, Morera J, Ruiz-Manzano J Ultrasound in Medicine and Biology 2.214
2012 Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia Guilera G, Gómez-Benito J, Pino O, Rojo JE, Cuesta MJ, Martínez-Arán A, Safont G, Tabarés-Seisdedos R, Vieta E, Bernardo M, Crespo-Facorro B, Franco M, Rejas J. Schizophrenia Research 3.923
2012 White matter development in adolescence: diffusion tensor imaging and meta-analytic results Peters BD, Szeszko PR, Radua J, Ikuta T, Gruner P, Derosse P, Zhang JP, Giorgio A, Qiu D, Tapert SF, Brauer J, Asato MR, Khong PL, James AC, Gallego JA, Malhotra AK Schizophrenia Bulletin 8.45
2012 The fall of the aypticals? McKenna P. British Journal of Psychiatry 7.991
2012 Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls Amann B, Gomar J, Ortiz-Gil J, McKenna PJ, Sans-Sansa B, Sarró S, Madre M, Landin R, Vieta E, Goikolea J, Sarró S, Salvador R, Moro N, Pomarol-Clotet E Psychological Medicine 5.938
2012 Structural correlates of auditory hallucinations in schizophrenia: a meta-analysis Palaniyappan L, Balain V, Radua J and Liddle PF Schizophrenia Research 3.923
2012 Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patients. Murru A, Pacchiarotti I, Nivoli AM, Bonnin CM, Patrizi B, Amann B, Vieta E, Colom F. Acta Psychiatrica Scandinavica 5.605
2012 Neurocognition in schizophrenia: a study of the productivity and visibility of Spanish authors Guilera G, Pino O, Gómez-Benito J, Rojo JE Psicothema 1.016
2012 On the parallel deterioration of lexico-semantic processes in the bilinguals' two languages: evidence from Alzheimer's disease Costa A, Calabria M, Marne P, Hernández M, Juncadella M, Gascón-Bayarri J, Lleó A, Ortiz-Gil J, Ugas L, Blesa R, Reñé R. Neuropsychologia 3.302
2012 Superior intellectual ability in schizophrenia: Neuropsychological characteristics Maccabe, J. H. Brebion, G. Reichenberg, A. Ganguly, T. McKenna, P. J. Murray, R. M. David, A. S. Neuropsychology 3.269
2012 Neuroanatomical maps of psychosis onset: Voxel-wise meta-Analysis of antipsychotic-naive VBM studies Fusar-Poli P, Radua J, McGuire P, Borgwardt S Schizophrenia Bulletin 8.45
2012 Increased familiarity of intellectual deficits in early-onset schizophrenia spectrum disorders Goldberg, X. Fatjo-Vilas, M. Munoz, M. J. Campanera, S. Miret, S. Minano, M. J. Aguilera, M. Miralles, M. L. Navarro, M. E. Lazaro, L. Guitart, M. Barrantes-Vidal, N. Fananas, L. World Journal Of Biological Psychiatry 4.183
2012 First-episode psychosis is characterized by failure of deactivation but not by hypo- or hyperfrontality. Guerrero-Pedraza A, McKenna PJ, Gomar JJ, Sarró S, Salvador R, Amann B, Carrión MI, Landin-Romero R, Blanch J, Pomarol-Clotet E. Psychological Medicine 5.938
2012 A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps Radua J, Mataix-Cols D, Phillips ML, El-Hage W, Kronhaus DM, Cardoner N and Surguladze S European Psychiatry 3.439
2012 Failure of de-activation in the medial frontal cortex in mania: evidence for default mode network dysfunction in the disorder E. Pomarol-Clotet, N. Moro, S. Sarro, J. M. Goikolea, E. Vieta, B. Amann, P. Fernandez-Corcuera, B. Sans-Sansa, G. C. Monte, A. Capdevila, P. J. McKenna and R. Salvador World Journal Of Biological Psychiatry 4.183
2011 Confabulations (II): Explicative Models Lorente-Rovira, E. McKenna, P. J. Berrios, G. E. Villagran-Moreno, J. M. Moro-Ipola, M. Actas Espanolas de Psiquiatria 1.2
2011 Six-month functional outcome of a bipolar disorder cohort in the context of a specialized-care program Rosa AR, Reinares M, Amann B, Popovic D, Franco C, Comes M, Torrent C, Bonnín CM, Solé B, Valentí M, Salamero M, Kapczinski F, Vieta E. Bipolar Disorders 4.965
2011 Development and Cross-Validation of the UPSA Short Form for the Performance-Based Functional Assessment of Patients With Mild Cognitive Impairment and Alzheimer Disease Gomar JJ, Harvey PD, Bobes-Bascaran MT, Davies P, Goldberg TE American Journal Of Geriatric Psychiatry 4.235
2011 Neurodevelopmental liability to schizophrenia: the complex mediating role of age at onset and premorbid adjustment Goldberg, X. Fatjo-Vilas, M. Penades, R. Miret, S. Munoz, M. J. Vossen, H. Fananas, L. Schizophrenia Research 3.923
2011 Functional cerebral activity in a state of rest: connectivity networks] Proal E, Alvarez-Segura M, de la Iglesia-Vayá M, Martí-Bonmatí L, Castellanos FX Revista de Neurologia 0.83
2011 Awareness of cognitive impairment in schizophrenia and its relationship to insight into illness. González-Suárez B, Gomar JJ, Pousa E, Ortiz-Gil J, García A, Salvador R, Sans-Sansa B, Pomarol-Clotet E, McKenna PJ. Schizophrenia Research 3.923
2011 Utility of Combinations of Biomarkers, Cognitive Markers, and Risk Factors to Predict Conversion From Mild Cognitive Impairment to Alzheimer Disease in Patients in the Alzheimer's Disease Neuroimaging Initiative J. J. Gomar, M. T. Bobes-Bascaran, C. Conejero-Goldberg, P. Davies and T. E. Goldberg JAMA Psychiatry 14.48
2011 Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication Nakao T, Radua J, Rubia K and Mataix-Cols D American Journal of Psychiatry 12.295
2011 Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression Puigdemont D, Perez-Egea R, Portella MJ, Molet J, de Diego-Adelino J, Gironell A, Radua J, Gomez-Anson B, Rodriguez R, Serra M, de Quintana C, Artigas F, Alvarez E and Perez V International Journal of Neuropsychopharmacology 4.009
2011 Restricted maximum likelihood estimation of PET neuroreceptor occupancy in the absence of a reference region Radua J, Bullich S, Lopez N and Catafau AM Medical Physics 2.635
2011 Confabulations (I): concept, classification and neuropathology E. Lorente-Rovira, G. Berrios, P. McKenna, M. Moro-Ipola and J. M. Villagran-Moreno Actas Espanolas de Psiquiatria 1.2
2011 The strategy of combining antidepressants in the treatment of major depression: clinical experience in spanish outpatients Martin-Lopez, L. M. Rojo, J. E. Gibert, K. Martin, J. C. Sperry, L. Duno, L. Bulbena, A. Vallejo, J. Depression Research and Treatment  
2011 Neural correlates of cognitive impairment in schizophrenia J. Ortiz-Gil, E. Pomarol-Clotet, R. Salvador, E. J. Canales-Rodriguez, S. Sarro, J. J. Gomar, A. Guerrero, B. Sans-Sansa, A. Capdevila, C. Junque and P. J. McKenna British Journal of Psychiatry 7.991
2011 Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SC Cuesta MJ, Pino O, Guilera G, Rojo JE, Gómez-Benito J, Purdon SE, Franco M, Martínez-Arán A, Segarra N, Tabarés-Seisdedos R, Vieta E, Bernardo M, Crespo-Facorro B, Mesa F, Rejas J Schizophrenia Research 3.923
2011 Comorbidity of delusional disorder with bipolar disorder: Report of four cases V. Vicens, S. Sarró, P.J. McKenna Journal of Affective Disorders 3.383
2011 Automated discrimination of brain pathological state attending to complex structural brain network properties: the shiverer mutant mouse case Y. Iturria-Medina, A. Perez Fernandez, P. Valdes Hernandez, L. Garcia Penton, E. J. Canales-Rodriguez, L. Melie-Garcia, A. L. Castellanos and M. O. Ortega PLoS One 3.234
2011 Asperger syndrome: can the disorder be diagnosed in the adult age? Sintes A, Arranz B, Ramírez N, Rueda I, San L. Actas Espanolas de Psiquiatria 1.2
2011 Meta-analysis of gray matter abnormalities in autism spectrum disorder: should Asperger disorder be subsumed under a broader umbrella of autistic spectrum disorder? Via E, Radua J, Cardoner N, Happe F and Mataix-Cols D JAMA Psychiatry 14.48
2011 Amygdala activity correlates with attentional bias in PTSD M. El Khoury-Malhame, E. Reynaud, A. Soriano, K. Michael, P. Salgado-Pineda, X. Zendjidjian, C. Gellato, F. Eric, M. N. Lefebvre, F. Rouby, J. C. Samuelian, J. L. Anton, O. Blin and S. Khalfa Neuropsychologia 3.302
2011 Contribution of SPECT Measurements of D2 and 5-HT2A Occupancy to the Clinical Development of the Antipsychotic SB-773812 A. M. Catafau, S. Bullich, G. Nucci, C. Burgess, F. Gray and E. Merlo-Pich Journal of Nuclear Medicine 6.16
2011 ECT in a patient with Parkinson's disease and schizophrenia, with dopamine transporter visualisation using 123I-Ioflupane SPET Fernández-Corcuera P, Aguilar S, Viçens V, Mora J, Benitez A, García-Burillo A, Pomarol-Clotet E, McKenna P Journal of Neural Transmission 2.402
2011 Correlated structural and functional brain abnormalities in the default mode network in schizophrenia patients. Salgado-Pineda P, Fakra E, Delaveau P, McKenna PJ, Pomarol-Clotet E, Blin O. Schizophrenia Research 3.923
2011 Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis Fatjo-Vilas, M. Papiol, S. Estrada, G. Bombin, I. Peralta, V. Rosa, A. Parellada, M. Miret, S. Martin, M. Lazaro, L. Campanera, S. Munoz, M. J. Lera-Miguel, S. Arias, B. Navarro, M. E. Castro-Fornieles, J. Cuesta, M. J. Arango, C. Fanana American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 3.416
2011 Neuroanatomical abnormalities in schizophrenia: A multimodal voxelwise meta-analysis and meta-regression analysis Bora E, Fornito A, Radua J, Walterfang M, Seal M, Wood SJ, Yucel M, Velakoulis D and Pantelis C Schizophrenia Research 3.923
2011 Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients C. Torrent, A. Martinez-Aran, C. Daban, B. Amann, V. Balanza-Martinez, C. Del Mar Bonnin, N. Cruz, C. Franco, R. Tabares-Seisdedos and E. Vieta Comprehensive Psychiatry 2.252
2011 Fronto-limbic dysfunction in borderline personality disorder: a 18F-FDG positron emission tomography study Salavert J, Gasol M, Vieta E, Cervantes A, Trampal C, Gispert JD Journal of Affective Disorders 3.383
2011 Predicting violence in psychiatric inpatients: a prospective study with the HCR-20 violence risk assessment scheme Arbach-Lucioni K, Andrés-Pueyo A, Pomarol-Clotet E, Gomar-Soñes J Journal of Forensic Psychiatry & Psychology 0.884
2011 Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism Estrada G, Fatjó-Vilas M, Muñoz MJ, Pulido G, Miñano MJ, Toledo E, Illa JM, Martín M, Miralles ML, Miret S, Campanera S, Bernabeu C, Navarro ME, Fañanás L Acta Psychiatrica Scandinavica 5.605
2011 Validation of the Word Accentuation Test (TAP) as a means of estimating premorbid IQ in Spanish speakers. Gomar JJ, Ortiz-Gil J, McKenna PJ, Salvador R, Sans-Sansa B, Sarró S, Guerrero A,Pomarol-Clotet E. Schizophrenia Research 3.923
2011 Oxytocin can hinder trust and cooperation in borderline personality disorder Bartz, J. Simeon, D. Hamilton, H. Kim, S. Crystal, S. Braun, A. Vicens, V. Hollander, E. Social cognitive and affective neuroscience 7.372
2011 Voxel-based meta-analysis of regional white-matter volume differences in autism spectrum disorder versus healthy controls Radua J, Via E, Catani M, Mataix-Cols D. Psychological Medicine 5.938
2011 Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder. D. Popovic, M. Reinares, B. Amann, M Salamero, E Vieta Psychopharmacology 3.875
2011 Disease-relevant autoantibodies in first episode schizophrenia Zandi, M. S. Irani, S. R. Lang, B. Waters, P. Jones, P. B. McKenna, P. Coles, A. J. Vincent, A. Lennox, B. R. Journal of Neurology 3.377
2011 Personality disorders and criminal responsibility in the Spanish supreme court Mohíno S, Pujol A, Idiaquez I Journal of forensic sciences 1.306
2011 Lamotrigine: when and where does it act in affective disorders? A systematic review Amann, B. Born, C. Crespo, J. M. Pomarol-Clotet, E. McKenna, P. Journal of Psychopharmacology 3.593
2011 Procedural learning in schizophrenia: reconciling the discrepant findings. Gomar JJ, Pomarol-Clotet E, Sarró S, Salvador R, Myers CE, McKenna PJ. Biological Psychiatry 10.255
2011 Negative schizophrenic symptoms and the frontal lobe syndrome: one and the same? Ziauddeen, H. Dibben, C. Kipps, C. Hodges, J. R. McKenna, P. J. European Archives Of Psychiatry And Clinical Neuroscience 3.525
2011 Olfactory reference syndrome: a systematic review of the world literature Begum, M. McKenna, P. J. Psychological Medicine 5.938
2011 Brain Hemispheric Structural Efficiency and Interconnectivity Rightward Asymmetry in Human and Nonhuman Primates Iturria-Medina, Y. Fernandez, A. P. Morris, D. M. Canales-Rodriguez, E. J. Haroon, H. A. Penton, L. G. Augath, M. Garcia, L. G. Logothetis, N. Parker, G. J. Melie-Garcia, L. Cerebral Cortex 8.665
2011 Neuropsychological profile of prodromal Alzheimer’s disease (Prd-AD) and their radiological correlates Jose L. Molinuevo, Beatriz Gomez-Anson, Gemma C. Monte, B. Bosch, Raquel Sanchez-Valle, Lorena Rami ́ Archives of Gerontology and Geriatrics 1.853
2010 Conditional mutual information maps as descriptors of net connectivity levels in the brain Salvador R, Anguera M, Gomar JJ, Bullmore ET, Pomarol-Clotet E Frontiers in Neuroinformatics 3.261
2010 Psychopathology in the 21st century. Musalek M, Larach-Walters V, Lépine JP, Millet B, Gaebel W; WFSBP Task Force on Nosology and Psychopathology. World Journal Of Biological Psychiatry 4.183
2010 Pernicious anaemia presenting as catatonia without signs of anaemia or macrocytosis S. Jauhar, A. Blackett, P. Srireddy and P. J. McKenna British Journal of Psychiatry 7.991
2010 Dopaminergic modulation of Default Mode Network in Parkinson's disease. Delaveau P, Salgado-Pineda P, Fossati P, Witjas T, Azulay JP, Blin O. European Neuropsychopharmacology 4.369
2010 Confabulation in schizophrenia: a neuropsychological study Llorente, Esther Santos-Gómez, J.L. Moro, M. Villagrán, J.M. Mckenna, Peter J Journal of the International Neuropsychological Society 2.963
2010 Functional Connectivity and Brain Networks in Schizophrenia Lynall, M. E. Bassett, D. S. Kerwin, R. McKenna, P. J. Kitzbichler, M. Muller, U. Bullmore, E. Journal of Neuroscience 6.344
2010 Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders Radua J, van den Heuvel OA, Surguladze S, Mataix-Cols D JAMA Psychiatry 14.48
2010 False memory in schizophrenia patients with and without delusions Bhatt, R. Laws, K. R. McKenna, P. J. Psychiatry Research 2.467
2010 COMT Val158Met polymorphism in relation to activation and de-activation in the prefrontal cortex: a study in patients with schizophrenia and healthy subjects Pomarol-Clotet, Edith Fatjó-Vilas, Mar McKenna, Peter J Monté, Gemma C Sarró, Salvador Ortiz-Gil, Jordi Aguirre, Candibel Gomar, Jesús J Guerrero, Amalia Landin, Ramón Capdevila, Antoni Fañanás,L Neuroimage 6.357
2010 Depression is associated with increased sensitivity to signals of disgust: a functional magnetic resonance imaging study Surguladze SA, El-Hage W, Dalgleish T, Radua J, Gohier B, Phillips ML Journal of Psychiatric Research 3.957
2010 Overall brain connectivity maps show cortico-subcortical abnormalities in schizophrenia R. Salvador, S. Sarró, J. Gomar, J. Ortiz-Gil, F. Vila, A. Capdevila, E. Bullmore, P. McKenna and E. Pomarol-Clotet. Human Brain Mapping 5.969
2010 Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging,. E. Pomarol-Clotet, R. Salvador, E. J. Canales-Rodriguez, S. Sarró, F. Vila, J. J. Gomar, J. Ortiz-Gil, A. Capdevila and P. J. McKenna. Molecular Psychiatry 14.496
2010 Climatic relationships with specific clinical subtypes of depression Radua, J. Pertusa, A. Cardoner, N. Psychiatry Research 2.467
2010 Differential patterns of initial and sustained amygdala and cortical responses to emotional stimuli in schizophrenia patients compared to healthy subjects. P. Salgado-Pineda, E. Fakra, P. Delaveau, O. Blin and A. Hariri. Journal Of Psychiatry & Neuroscience 5.861
2010 Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant. Hwang R, Zai C, Tiwari A, Muller DJ, Arranz MJ, Morris AG, McKenna PJ, Munro J, Potkin SG, Lieberman JA, Meltzer HY, Kennedy JL. Pharmacogenomics Journal 4.229
2010 Medial Temporal Lobe Correlates of Memory Screening Measures in Normal Ageing, MCI, and AD G. Sanchez-Benavides, B. Gomez-Anson, J. L. Molinuevo, R. Blesa, G. C. Monte, H. Buschke and J. Pena-Casanova Journal of Geriatric Psychiatry and Neurology 2.242
2010 Imaging cortical dopamine D1 receptors using Catafau, A. M. Searle, G. E. Bullich, S. Gunn, R. N. Rabiner, E. A. Herance, R. Radua, J. Farre, M. Laruelle, M. Journal of Cerebral Blood Flow and Metabolism 5.407
2010 Deconvolution in Diffusion Spectrum Imaging. E. J. Canales-Rodríguez, Y. Iturria-Medina, Y. Aleman-Gomez and L. Melie-Garcia. Neuroimage 6.357
2010 Are There Valid Subtypes of Schizophrenia? A Grade of Membership Analysis. E. Pomarol-Clotet, R. Salvador, G. Murray, S. Tandon and P. J. McKenna. Psychopathology 2.084
2010 Predictors of schizophrenia in patients with a first episode of psychosis. Ramirez N, Arranz B, Salavert J, Alvarez E, Corripio I, Dueñas RM, Perez V, San L. Psychiatry Research 2.467
2010 Diffusion Orientation Transform Revisited. E. J. Canales-Rodriguez, C. P. Lin, Y. Iturria-Medina, C. H. Yeh, K. H. Cho and L. Melie-Garcia. Neuroimage 6.357
2010 Facial emotion processing in schizophrenia: a non-specific neuropsychological deficit? E. Pomarol-Clotet, F. Hynes, C. Ashwin, E. T. Bullmore, P. J. McKenna and K. R. Laws. Psychological Medicine 5.938
2010 Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) Rojo, E. Pino, O. Guilera, G. Gomez-Benito, J. Purdon, S. E. Crespo-Facorro, B. Cuesta, M. J. Franco, M. Martinez-Aran, A. Segarra, N. Tabares-Seisdedos, R. Vieta, E. Bernardo, M. Mesa, F. Rejas, J. Spanish Working Group in Cognitive, Funct Schizophrenia Research 3.923
2010 Neural response to specific components of fearful faces in healthy and schizophrenic adults Radua, J. Phillips, M. L. Russell, T. Lawrence, N. Marshall, N. Kalidindi, S. El-Hage, W. McDonald, C. Giampietro, V. Brammer, M. J. David, A. S. Surguladze, S. A. Neuroimage 6.357
2010 IQ-Related fMRI Differences during Cognitive Set Shifting. S. Graham, J. Jiang, V. Manning, A. B. Nejad, K. Zhisheng, S. R. Salleh, X. Golay, Y. I. Berne and P. J. McKenna. Cerebral Cortex 8.665
2010 Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials. D. Lynch, K. R. Laws and P. J. McKenna. Psychological Medicine 5.938
2009 An investigation of temperamental traits of patients with somatoform disorder: Do they belong to the affective spectrum? . B. Amann, F. Padberg, R. Mergl, T. Baghai, K. Reimers, N. El-Giamal, A. Erfurth and G. Laakmann. Psychosomatics 1.858
2009 Dopaminergic modulation of amygdala activity during emotion recognition in patients with Parkinson disease. P. Delaveau, P. Salgado-Pineda, T. Witjas, J. Micallef-Roll, E. Fakra, J. P. Azulay and O. Blin. Journal of Clinical Psychopharmacology 3.243
2009 CamBAfx: Workflow Design, Implementation and Application for Neuroimaging Ooi C, Bullmore ET, Wink AM, Sendur L, Barnes A, Achard S, Aspden J, Abbott S, Yue S, Kitzbichler M, Meunier D, Maxim V, Salvador R, Henty J, Tait R, Subramaniam N, Suckling J Frontiers in Neuroinformatics 3.261
2009 [Metabolic syndrome and ageing: cognitive impairment and structural alterations of the central nervous system] Segura, B. Jurado, M. A. Revista de Neurologia 0.83
2009 Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study Segura, B. Jurado, M. A. Freixenet, N. Falcon, C. Junque, C. Arboix, A. Neurology 8.286
2009 Mental slowness and executive dysfunctions in patients with metabolic syndrome Segura, B. Jurado, M. A. Freixenet, N. Albuin, C. Muniesa, J. Junque, C. Neuroscience Letters 2.03
2009 Anticonvulsants in the treatment of aggression in the demented elderly: an update Amann B, Pantel J, Grunze H, Vieta E, Colom F, Gonzalez-Pinto A, Naber D, Hampel H Clinical Practice and Epidemiology in Mental Health  
2009 Formal Thought Disorder, Neuropsychology and Insight in Schizophrenia. A. Barrera, P. J. McKenna and G. E. Berrios. Psychopathology 2.084
2009 Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology. C. Born, N. N. Seitz, H. Grunze, E. Vieta, S. Dittmann, F. Seemuller and B. Amann. Acta Psychiatrica Scandinavica 5.605
2009 Targeting cognition in schizophrenia research: from etiology to treatment. T. E. Goldberg and J. J. Gomar. American Journal of Psychiatry 12.295
2009 Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis M. Guevara, M. E. Baccaro, A. Torre, B. Gomez-Anson, J. Rios, F. Torres, L. Rami, G. C. Monte-Rubio, M. Martin-Llahi, V. Arroyo and P. Gines. American Journal of Gastroenterology 10.755
2009 Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder. G. Guilera, O. Pino, J. Gomez-Benito, J. E. Rojo, E. Vieta, R. Tabares-Seisdedos, N. Segarra, A. Martinez-Aran, M. Franco, M. J. Cuesta, B. Crespo-Facorro, M. Bernardo, S. E. Purdon, T. Diez and J. Rejas. Health and Quality of Life Outcomes 2.12
2009 Mathematical description of q-space in spherical coordinates: exact q-ball imaging. E. J. Canales-Rodriguez, L. Melie-Garcia and Y. Iturria-Medina. Magnetic Resonance in Medicine 3.571
2009 Early metabolic characteristics of lesion and nonlesion tissue after head injury. J. P. Coles, A. S. Cunningham, R. Salvador, D. A. Chatfield, A. Carpenter, J. D. Pickard and D. K. Menon. Journal of Cerebral Blood Flow and Metabolism 5.407
2009 Voxel based morphometry features and follow-up of amnestic patients at high risk for Alzheimer's disease conversion L. Rami, B. Gomez-Anson, G. C. Monte, B. Bosch, R. Sanchez-Valle and J. L. Molinuevo International Journal Of Geriatric Psychiatry 2.866
2009 Abnormal temperament in patients with morbid obesity seeking surgical treatment. B. Amann, R. Mergl, C. Torrent, G. Perugi, F. Padberg, N. El-Gjamal and G. Laakmann. Journal of Affective Disorders 3.383
2009 Within-subject comparison of striatal D2 receptor occupancy measurements using A. M. Catafau, M. Suarez, S. Bullich, J. Llop, G. Nucci, R. N. Gunn, C. Brittain and M. Laruelle. Neuroimage 6.357
2009 Treatment-refractory schizoaffective disorder in a patient with dyke-davidoff-masson syndrome. B. Amann, C. Garcia de la Iglesia, P. McKenna, E. Pomarol-Clotet, M. Sanchez-Guerra and M. Orth. CNS Spectrums 2.71
2009 Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study S. J. Price, T. D. Fryer, M. C. Cleij, A. F. Dean, J. Joseph, R. Salvador, D. D. Wang, P. J. Hutchinson, J. C. Clark, N. G. Burnet, J. D. Pickard, F. I. Aigbirhio and J. H. Gillard Clinical Radiology 1.759
2009 Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis. Arranz B, San L, Ramírez N, Dueñas RM, Perez V, Salavert J, Corripio I, Alvarez E. Acta Psychiatrica Scandinavica 5.605
2009 Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. B. Gomez-Anson, M. Alegret, E. Munoz, G. C. Monte, E. Alayrach, A. Sanchez, M. Boada and E. Tolosa Parkinsonism & Related Disorders 3.972
2009 Is executive impairment associated with schizophrenic syndromes? A meta-analysis. C. R. Dibben, C. Rice, K. Laws and P. J. McKenna. Psychological Medicine 5.938
2009 Risperidone versus haloperidol for facial affect recognition in schizophrenia: Findings from a randomised study. E. Fakra, P. Salgado-Pineda, N. Besnier, J. M. Azorin and O. Blin. World Journal Of Biological Psychiatry 4.183
2008 Risk of harm after psychological intervention. P. J. McKenna, R. Salvador, D. Lynch and K. R. Laws. British Journal of Psychiatry 7.991
2008 Inferring multiple maxima in intravoxel white matter fiber distribution. E. J. Canales-Rodriguez, L. Melie-Garcia, Y. Iturria-Medina, E. Martinez-Montes, Y. Aleman-Gomez and C. P. Lin. Magnetic Resonance in Medicine 3.571
2008 Identifying the risk of deliberate self-harm among young prisoners by means of coping typologies Kirchner T, Forns M, Mohíno S Suicide and Life-Threatening Behavior  
2008 [Psychogeriatrics 2006-2007] Regalado PJ, Azpiazu P, Pujol J Revista Española de Geriatría y Gerontología  
2008 New evidences of gene and environment interactions affecting prenatal neurodevelopment in schizophrenia-spectrum disorders: A family dermatoglyphic study. M. Fatjo-Vilas, D. Gourion, S. Campanera, F. Mouaffak, M. Levy-Rueff, M. E. Navarro, M. Chayet, S. Miret, M. O. Krebs and L. Fananas. Schizophrenia Research 3.923
2008 A Bayesian framework to identify principal intravoxel diffusion profiles based on diffusion-weighted MR imaging. L. Melie-Garcia, E. J. Canales-Rodriguez, Y. Aleman-Gomez, C. P. Lin, Y. Iturria-Medina and P. A. Valdes-Hernandez. Neuroimage 6.357
2008 Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. G. D. Honey, P. R. Corlett, A. R. Absalom, M. Lee, E. Pomarol-Clotet, G. K. Murray, P. J. McKenna, E. T. Bullmore, D. K. Menon and P. C. Fletcher. Journal of Neuroscience 6.344
2008 Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration? G. D. Kotzalidis, I. Pacchiarotti, G. Manfredi, V. Savoja, C. Torrent, L. Mazzarini, C. Tatarelli, B. Amann, S. Di Marzo, J. Sanchez-Moreno, G. Sani, P. Girardi, F. Colom and E. Vieta. Journal of Psychopharmacology 3.593
2008 Failure to deactivate in the prefrontal cortex in schizophrenia: dysfunction of the default mode network? E. Pomarol-Clotet, R. Salvador, S. Sarro, J. Gomar, F. Vila, A. Martinez, A. Guerrero, J. Ortiz-Gil, B. Sans-Sansa, A. Capdevila, J. M. Cebamanos and P. J. McKenna. Psychological Medicine 5.938
2008 Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. C. Torrent, B. Amann, J. Sanchez-Moreno, F. Colom, M. Reinares, M. Comes, A. R. Rosa, J. Scott and E. Vieta. Acta Psychiatrica Scandinavica 5.605
2008 Abnormal P300 in people with high risk of developing psychosis. E. Bramon, M. Shaikh, M. Broome, J. Lappin, D. Berge, F. Day, J. Woolley, P. Tabraham, M. Madre, L. Johns, O. Howes, L. Valmaggia, V. Perez, P. Sham, R. M. Murray and P. McGuire. Neuroimage 6.357
2008 Myoclonus provoked by lamotrigine in a bipolar patient. P. Fernandez Corcuera, E. Pomarol-Clotet, B. Amann and P. McKenna. Journal of Clinical Psychopharmacology 3.243
2008 Studying the human brain anatomical network via diffusion-weighted MRI and Graph Theory. Y. Iturria-Medina, R. C. Sotero, E. J. Canales-Rodriguez, Y. Aleman-Gomez and L. Melie-Garcia. Neuroimage 6.357
2008 Personality and Coping in Young Inmates: A Cluster Typology. S. Mohino, T. Kirchner and M. Forns. Psychopathology 2.084
2008 Semantic priming in schizophrenia: systematic review and meta-analysis. E. Pomarol-Clotet, T. M. Oh, K. R. Laws and P. J. McKenna. British Journal of Psychiatry 7.991
2008 Neural bases of different cognitive strategies for facial affect processing in schizophrenia. E. Fakra, P. Salgado-Pineda, P. Delaveau, A. R. Hariri and O. Blin. Schizophrenia Research 3.923
2008 The effect of drug concentration expression on epinephrine dosing errors: a randomized trial. D. W. Wheeler, J. J. Carter, L. J. Murray, B. A. Degnan, C. P. Dunling, R. Salvador, D. K. Menon and A. K. Gupta. Annals of Internal Medicine 17.81
2008 Two new scales of formal thought disorder in schizophrenia. A. Barrera, P. J. McKenna and G. E. Berrios. Psychiatry Research 2.467
2008 Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia. O. Pino, G. Guilera, J. E. Rojo, J. Gomez-Benito, M. Bernardo, B. Crespo-Facorro, M. J. Cuesta, M. Franco, A. Martinez-Aran, N. Segarra, R. Tabares-Seisdedos, E. Vieta, S. E. Purdon, T. Diez and J. Rejas. Schizophrenia Research 3.923
2008 A simple view of the brain through a frequency-specific functional connectivity measure. R. Salvador, A. Martinez, E. Pomarol-Clotet, J. Gomar, F. Vila, S. Sarro, A. Capdevila and E. Bullmore. Neuroimage 6.357
2008 Memory and executive impairment in schizophrenia: comparison with frontal and temporal brain damage. T. J. Ornstein, B. J. Sahakian and P. J. McKenna. Psychological Medicine 5.938
2007 Amygdala activation modulated by levodopa during emotional recognition processing in healthy volunteers: a double-blind, placebo-controlled study. P. Delaveau, P. Salgado-Pineda, J. Micallef-Roll and O. Blin. Journal of Clinical Psychopharmacology 3.243
2007 Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects. C. Torrent, A. Martinez-Aran, B. Amann, C. Daban, R. Tabares-Seisdedos, A. Gonzalez-Pinto, M. Reinares, A. Benabarre, M. Salamero, P. McKenna and E. Vieta. Acta Psychiatrica Scandinavica 5.605
2007 Risperidone monotherapy in manic inpatients: An open label, multicentre trial. A. Forsthoff, H. Grunze, F. Seemuller, R. Stampfer, S. Dittmann, B. Amann, F. Schmidt, M. Schafer, L. Hermle, J. Walden and A. Schreiner. World Journal Of Biological Psychiatry 4.183
2007 Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. R. M. Procyshyn, K. M. Wasan, A. E. Thornton, A. M. Barr, E. Y. Chen, E. Pomarol-Clotet, E. Stip, R. Williams, G. W. Macewan, C. L. Birmingham and W. G. Honer. Journal Of Psychiatry & Neuroscience 5.861
2007 Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. R. M. Craddock, H. E. Lockstone, D. A. Rider, M. T. Wayland, L. J. Harris, P. J. McKenna and S. Bahn. PLoS One 3.234
2007 Low baseline serotonin-2A receptors predict clinical response to olanzapine in first-episode schizophrenia patients. B. Arranz, P. Rosel, L. San, N. Ramirez, R. M. Duenas, J. Salavert, M. Centeno and E. D. Moral. Psychiatry Research 2.467
2007 Antiepileptic drugs and mood stability. B. Amann, H. Grunze, E. Vieta and M. Trimble. Clinical Eeg and Neuroscience 2.219
2007 [Electroconvulsive therapy in the treatment of bipolar depression]. M. Valenti, A. Benabarre, M. Bernardo, M. Garcia-Amador, B. Amann and E. Vieta. Actas Espanolas de Psiquiatria 1.2
2007 Confabulation in schizophrenia and its relationship to clinical and neuropsychological features of the disorder. E. Lorente-Rovira, E. Pomarol-Clotet, R. A. McCarthy, G. E. Berrios and P. J. McKenna. Psychological Medicine 5.938
2007 Family-based association study of neuregulin-1 gene and psychosis in a Spanish sample. A. Rosa, M. Gardner, M. J. Cuesta, V. Peralta, M. Fatjo-Vilas, S. Miret, M. E. Navarro, D. Comas and L. Fananas. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 3.416
2007 Characterizing brain anatomical connections using diffusion weighted MRI and graph theory. Y. Iturria-Medina, E. J. Canales-Rodriguez, L. Melie-Garcia, P. A. Valdes-Hernandez, E. Martinez-Montes, Y. Aleman-Gomez and J. M. Sanchez-Bornot. Neuroimage 6.357
2007 Psychological adjustment in a forensic sample: relationship with approach- and avoidance-coping typologies Kirchner T, Forns M, Mohíno S Journal of forensic sciences 1.306
2007 Creative thinking in schizophrenia: the role of executive dysfunction and symptom severity Abraham A, Windmann S, McKenna P, Güntürkün O Cognitive Neuropsychiatry 1.912
2007   N. Ramirez, B. Arranz, C. Martin and L. San. Actas Espanolas de Psiquiatria 1.2
2007 A sibutramine-induced delusional disorder relapse. P. Fernandez and A. Peiro. Journal Of Neuropsychiatry And Clinical Neurosciences 2.817
2007 Schizophrenia and frontal cortex: where does it fail? P. Salgado-Pineda, A. Caclin, I. Baeza, C. Junque, M. Bernardo, O. Blin and P. Fonlupt. Schizophrenia Research 3.923
2007 Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia. L. Menzies, C. Ooi, S. Kamath, J. Suckling, P. McKenna, P. Fletcher, E. Bullmore and C. Stephenson. JAMA Psychiatry 14.48
2007 Frequency based mutual information measures between clusters of brain regions in functional magnetic resonance imaging. R. Salvador, A. Martinez, E. Pomarol-Clotet, S. Sarro, J. Suckling and E. Bullmore. Neuroimage 6.357
2007 A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant Rapid-Cycling Bipolar Disorder. B. L. Amann, R. Mergl, E. Vieta, C. Born, I. Hermisson, F. Seemueller, S. Dittmann and H. Grunze. Journal of Clinical Psychopharmacology 3.243
2007 Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients Arranz B, San L, Dueñas RM, Centeno M, Ramirez N, Salavert J, Del Moral E Human Psychopharmacology-Clinical And Experimental 2.192
2006 Probabilistic reasoning in schizophrenia: a comparison of the performance of deluded and nondeluded schizophrenic patients and exploration of possible cognitive underpinnings Menon M, Pomarol-Clotet E, McKenna PJ, McCarthy RA Cognitive Neuropsychiatry 1.912
2006 An exploratory open trial on safety and efficacy of the anticonvulsant retigabine in acute manic patients. B. Amann, A. Sterr, E. Vieta, R. Stampfer, J. Walden and H. Grunze. Journal of Clinical Psychopharmacology 3.243
2006 Formal thought disorder is characterised by impaired lexical access. V. C. Leeson, K. R. Laws and P. J. McKenna. Schizophrenia Research 3.923
2006 What works in schizophrenia: cognitive behaviour therapy is not effective. P. J. McKenna. BMJ-British Medical Journal 17.445
2006 Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Case report. U. D. Parthasarathi, T. Harrower, M. Tempest, J. R. Hodges, C. Walsh, P. J. McKenna and P. C. Fletcher. British Journal of Psychiatry 7.991
2006 Psychological effects of ketamine in healthy volunteers. Phenomenological study. E. Pomarol-Clotet, G. D. Honey, G. K. Murray, P. R. Corlett, A. R. Absalom, M. Lee, P. J. McKenna, E. T. Bullmore and P. C. Fletcher. British Journal of Psychiatry 7.991
2006 [A naturalistic study: 100 consecutive episodes of acute agitation in a psychiatric emergency department]. J. C. Pascual, M. Madre, D. Puigdemont, S. Oller, I. Corripio, A. Diaz, G. Faus, V. Perez and E. Alvarez. Actas Espanolas de Psiquiatria 1.2
2006 Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study. P. Salgado-Pineda, P. Delaveau, C. Falcon and O. Blin. British Journal of Clinical Pharmacology 3.878
2006 Effects of antidepressant drugs on emotion. M. Serra, P. Salgado-Pineda, P. Delaveau, E. Fakra, C. Gasto and O. Blin. Clinical Neuropharmacology 2.009
2006 Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. P. R. Corlett, G. D. Honey, M. R. Aitken, A. Dickinson, D. R. Shanks, A. R. Absalom, M. Lee, E. Pomarol-Clotet, G. K. Murray, P. J. McKenna, T. W. Robbins, E. T. Bullmore and P. C. Fletcher. JAMA Psychiatry 14.48
2006 Injectable atypical antipsychotics for agitation in borderline personality disorder. J. C. Pascual, M. Madre, J. Soler, J. Barrachina, M. J. Campins, E. Alvarez and V. Perez. Pharmacopsychiatry 1.851
2006 Permutation testing of orthogonal factorial effects in a language-processing experiment using fMRI. J. Suckling, M. H. Davis, C. Ooi, A. M. Wink, J. Fadili, R. Salvador, D. Welchew, L. Sendur, V. Maxim and E. T. Bullmore. Human Brain Mapping 5.969
2006 Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline. A. Sterr, F. Padberg, B. Amann, R. Mergl, C. Mulert, G. Juckel, U. Hegerl and O. Pogarell. Journal of Clinical Psychiatry 5.498
2006 A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia Perez, V. Canas, F. Tafalla, M. Tesis Study Group International Clinical Psychopharmacology 2.456
2006 Clozapine alone versus clozapine and risperidone with refractory schizophrenia. W. G. Honer, A. E. Thornton, E. Y. Chen, R. C. Chan, J. O. Wong, A. Bergmann, P. Falkai, E. Pomarol-Clotet, P. J. McKenna, E. Stip, R. Williams, G. W. MacEwan, K. Wasan and R. Procyshyn. New England Journal of Medicine 55.873
2006 A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. S. Achard, R. Salvador, B. Whitcher, J. Suckling and E. Bullmore. Journal of Neuroscience 6.344
2006 Influence of improved teaching on medical students' acquisition and retention of drug administration skills Wheeler DW, Whittlestone KD, Salvador R, Wood DF, Johnston AJ, Smith HL, Menon DK British Journal of Anaesthesia 4.853
2006 Age and cholinergic effects on hemodynamics and functional coherence of human hippocampus. A. M. Wink, F. Bernard, R. Salvador, E. Bullmore and J. Suckling. Neurobiology of Aging 5.013
2006 The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia. G. D. Honey, C. O'Loughlin, D. C. Turner, E. Pomarol-Clotet, P. R. Corlett and P. C. Fletcher. Neuropsychopharmacology 7.048
2005 Effect of levodopa on healthy volunteers' facial emotion perception: an FMRI study. P. Delaveau, P. Salgado-Pineda, B. Wicker, J. Micallef-Roll and O. Blin. Clinical Neuropharmacology 2.009
2005 Heightened stimulus salience renders deluded schizophrenics less susceptible to the 'famous names illusion'. M. Menon, T. S. Woodward, E. Pomarol-Clotet, P. J. McKenna and R. McCarthy. Schizophrenia Research 3.923
2005 Dopaminergic contribution to the regulation of emotional perception. P. Salgado-Pineda, P. Delaveau, O. Blin and A. Nieoullon. Clinical Neuropharmacology 2.009
2005 Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function. G. D. Honey, E. Pomarol-Clotet, P. R. Corlett, R. A. Honey, P. J. McKenna, E. T. Bullmore and P. C. Fletcher. Brain 9.196
2005 Estimating brain functional connectivity with sparse multivariate autoregression. P. A. Valdes-Sosa, J. M. Sanchez-Bornot, A. Lage-Castellanos, M. Vega-Hernandez, J. Bosch-Bayard, L. Melie-Garcia and E. Canales-Rodriguez. Philosophical Transactions Of The Royal Society B-Biological Sciences 7.055
2005 Linguistic adaptation and validation into Spanish of the Diagnostic Interview for Borderline Personality Disorders-Revised (DIB-R). N. Szerman, M. D. Peris, A. Ruiz, M. Ruiz, J. G. Gunderson and J. Rejas. Current Medical Research and Opinion 2.653
2005 Storage and access procedures in schizophrenia: evidence for a two phase model of lexical impairment. V. C. Leeson, P. J. McKenna and K. R. Laws. Journal of Clinical and Experimental Neuropsychology 2.083
2005 Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. B. Ramirez-Ruiz, M. J. Marti, E. Tolosa, D. Bartres-Faz, C. Summerfield, P. Salgado-Pineda, B. Gomez-Anson and C. Junque. Anatomical Record 1.542
2005 Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task. G. D. Honey, R. A. Honey, S. R. Sharar, D. C. Turner, E. Pomarol-Clotet, D. Kumaran, J. S. Simons, X. Hu, M. D. Rugg, E. T. Bullmore and P. C. Fletcher. Psychopharmacology 3.875
2005 Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. L. A. Templeman, G. P. Reynolds, B. Arranz and L. San. Pharmacogenetics and Genomics 3.481
2005 Reboxetine for the treatment of patients with Cocaine Dependence Disorder Szerman N, Peris L, Mesías B, Colis P, Rosa J, Prieto A Human Psychopharmacology-Clinical And Experimental 2.192
2005 Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. G. Massana, P. Salgado-Pineda, C. Junque, M. Perez, I. Baeza, A. Pons, J. Massana, V. Navarro, J. Blanch, A. Morer, J. M. Mercader and M. Bernardo. Journal of Clinical Psychopharmacology 3.243
2005 Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. C. Summerfield, C. Junque, E. Tolosa, P. Salgado-Pineda, B. Gomez-Anson, M. J. Marti, P. Pastor, B. Ramirez-Ruiz and J. Mercader. ARCHIVES OF NEUROLOGY 7.419
2005 Cerebral correlates of declarative memory dysfunctions in early traumatic brain injury. J. M. Serra-Grabulosa, C. Junque, K. Verger, P. Salgado-Pineda, C. Maneru and J. M. Mercader. Journal Of Neurology Neurosurgery And Psychiatry 6.807
2004 Augmentation of electroconvulsive therapy seizures with sleep deprivation. E. Gilabert, E. Rojo and J. Vallejo. Journal of ECT 1.389
2004 Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients. B. Arranz, P. Rosel, N. Ramirez, R. Duenas, P. Fernandez, J. M. Sanchez, M. A. Navarro and L. San. Journal of Clinical Psychiatry 5.498
2004 Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia. S. J. Keith, L. Pani, B. Nick, R. Emsley, L. San, M. Turner, R. Conley, P. Scully, P. S. Chue and B. Lachaux. Psychiatric Services 2.412
2004 Reboxetine adjunct for partial or nonresponders to antidepressant treatment. G. Rubio, L. San, F. Lopez-Munoz and C. Alamo. Journal of Affective Disorders 3.383
2004 Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. P. Rosel, B. Arranz, M. Urretavizcaya, M. Oros, L. San and M. A. Navarro. Neuropsychobiology 2.261
2004 Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia. S. Sarro, R. M. Duenas, N. Ramirez, B. Arranz, R. Martinez, J. M. Sanchez, J. M. Gonzalez, L. Salo, L. Miralles and L. San. Dentomaxillofacial Radiology 1.39
2004 Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. D. C. Turner, L. Clark, E. Pomarol-Clotet, P. McKenna, T. W. Robbins and B. J. Sahakian. Neuropsychopharmacology 7.048
2004 [Rhabdomyolysis due to polydipsia in a patient with psychotic disorder]. N. Ramirez, B. Arranz, S. Sarro and L. San. Actas Espanolas de Psiquiatria 1.2
2003 [Combination therapy with reboxetine for major depression patients who are partial or nonresponders to serotonin selective reuptake inhibitors]. G. Rubio, L. San, F. Lopez-Munoz, P. Garcia-Garcia and C. Alamo. Actas Espanolas de Psiquiatria 1.2
2003 [Cannabis dependence: clinical implications. Based and one case]. P. Fernandez Corcuera, L. Tiffon, J. Sole and L. San. Actas Espanolas de Psiquiatria 1.2
2003 Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients. B. Arranz, P. Rosel, S. Sarro, N. Ramirez, R. Duenas, R. Cano, J. M. Sanchez and L. San. Psychiatry Research 2.467
2003 Combined use of platelet serotonergic markers and psychopathological scales as diagnostic screening of a psychotic versus a depressive disorder. N. Ramirez, B. Arranz, C. Martin and L. San. European Psychiatry 3.439
2002 Depression improvement with calcium heparin. S. Sarró (S. S. Maluquer), B. Arranz and L. San. General Hospital Psychiatry 2.606
2002 Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT(2A) receptors in Brodmann areas and brain hemispheres. P. Rosel, B. Arranz, M. Urretavizcaya, M. Oros, L. San, J. Vallejo and M. A. Navarro. Psychiatry Research 2.467
2002 Loss of the circadian variation of platelet J. Vallejo, P. Rosel, B. Arranz, M. Urretavizcaya, J. M. Menchon, F. Contreras and M. A. Navarro. Journal of Affective Disorders 3.383
2001 [Depressive symptoms in dementia. The Cornell scale: validation of the Spanish version]. J. Pujol, P. De Azpiazu, M. Salamero and R. Cuevas. Revista de Neurologia 0.83
2001 [Instruments of depression assessment in schizophrenia]. N. Ramirez, S. Sarro, B. Arranz, J. Sanchez, J. Gonzalez and L. San. Actas Espanolas de Psiquiatria 1.2
2001 Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. P. Wright, M. Birkett, S. R. David, K. Meehan, I. Ferchland, K. J. Alaka, J. C. Saunders, J. Krueger, P. Bradley, L. San, M. Bernardo, M. Reinstein and A. Breier. American Journal of Psychiatry 12.295
2001 Genetic dysfunction of the serotonin receptor 5-HT2A in psychiatric disorders]. B. Arranz, P. Rosel, N. Ramirez and L. San. Actas Espanolas de Psiquiatria 1.2
2000 Electroconvulsive therapy and serotonergic system]. N. Ramirez, B. Arranz, R. M. Duenas and L. San. Actas Espanolas de Psiquiatria 1.2
2000 Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims. P. Rosel, B. Arranz, L. San, J. Vallejo, J. M. Crespo, M. Urretavizcaya and M. A. Navarro. Psychiatry Research 2.467
2000 Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): psychomotor performance and subjective effects. J. Cami, M. Farre, M. Mas, P. N. Roset, S. Poudevida, A. Mas, L. San and R. de la Torre. Journal Of Child Psychology And Psychiatry 6.459
1999 Future research directions and the impact of the MATCH project on research technology in the addictions. L. San. Addiction 4.738
1999 Pros and cons of ultrarapid opiate detoxification. L. San and B. Arranz. Addiction 4.738
1999 Platelet serotonergic binding sites in alcohol-dependent patients Arranz B, Rosel P, Sarró S, Zaldivar E, Cano R, Navarro MA, San L Alcohol and alcoholism 2.889
1999 Altered P. Rosel, B. Arranz, J. Vallejo, P. Alvarez, J. M. Menchon, T. Palencia and M. A. Navarro. Journal of Affective Disorders 3.383
1999 Immunological screening of drugs of abuse and gas chromatographic-mass spectrometric confirmation of opiates and cocaine in hair Segura J, Stramesi C, Redón A, Ventura M, Sanchez CJ, González G, San L, Montagna M Journal of Chromatography B-Analytical Technologies in the Biomedical 2.729
1999 Methadone and quality of life. M. Torrens, A. Domingo-Salvany, J. Alonso, C. Castillo and L. San. Lancet 45.217
1998 Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program. M. Torrens, C. Castillo, L. San, E. del Moral, M. L. Gonzalez and R. de la Torre. Drug and Alcohol Dependence 3.423
1998 Characterization of the 5-HT4 binding site in human brain. B. Arranz, P. Rosel, L. San, S. Sarro, M. A. Navarro and J. Marcusson. Journal of Neural Transmission 2.402
1998 Variations in P. Rosel, B. Arranz, J. Vallejo, M. Oros, J. M. Crespo, J. M. Menchon and M. A. Navarro. Psychiatry Research 2.467
1998 Monitoring patterns of substance use in drug-dependent patients San L, Torrens M, Tato J, Castillo C, de la Torre R, Arranz B Journal of Substance Abuse Treatment  
1997 [Alcohol dependence and the serotoninergic system: therapeutic implications]. B. Arranz and L. San. Medicina Clinica 1.417
1997 Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. M. Torrens, L. San, A. Martinez, C. Castillo, A. Domingo-Salvany and J. Alonso. Addiction 4.738
1997 Platelet P. Rosel, J. M. Menchon, J. Vallejo, B. Arranz, M. A. Navarro, F. Liron and P. Alvarez. Journal of Affective Disorders 3.383
1997 Serotonergic, noradrenergic, and dopaminergic measures in suicide brains. B. Arranz, K. Blennow, A. Eriksson, J. E. Mansson and J. Marcusson. Biological Psychiatry 10.255
1997 High affinity P. Rosel, B. Arranz, J. Vallejo, M. Oros, J. M. Menchon, P. Alvarez and M. A. Navarro. Journal of Neural Transmission 2.402
1997 Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain. P. Rosel, J. M. Menchon, M. Oros, J. Vallejo, T. Cortadellas, B. Arranz, P. Alvarez and M. A. Navarro. Journal of Neural Transmission 2.402
1997 Routine detection of point mutations in non-classic steroid 21-hydroxylase Machuca I, Ibañez L, Bonnín MR, Rosel P, Arranz B, Navarro MA International Journal of Clinical and Laboratory Research  
1995 High risk of ultrashort noninvasive opiate detoxification. L. San, M. Puig, A. Bulbena and M. Farre. American Journal of Psychiatry 12.295